Growth Metrics

Globus Medical (GMED) Depreciation & Amortization - Total (2024 - 2025)

Globus Medical posted quarterly Depreciation & Amortization - Total of $30.1 million for Q3 2025, up 7.1% year-on-year from $28.1 million in Q3 2024, and up 1.5% on a QoQ basis from $29.6 million in Q2 2025.

Globus Medical (GMED) has 2 years of Depreciation & Amortization - Total data on file, last reported at $30.1 million in Q3 2025.

  • For the quarter ending Q3 2025, Depreciation & Amortization - Total rose 7.1% year-over-year to $30.1 million; the trailing twelve-month figure through Mar 2026 stood at $59.7 million (down 46.93% YoY), and the FY2024 full-year result was $100.9 million, up 40.66% from the prior year.
  • Depreciation & Amortization - Total for Q3 2025 stood at $30.1 million, up from $29.6 million in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $30.1 million in Q3 2025 and bottomed at $17.3 million in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Globus Medical 10.79 Bn 10.16 Bn 525.79 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 30.08 Mn
Jun 30, 2025 29.64 Mn
Mar 31, 2025 28.97 Mn
Dec 31, 2024 29.27 Mn
Sep 30, 2024 28.09 Mn
Jun 30, 2024 26.20 Mn
Mar 31, 2024 17.34 Mn